For clinicians
Resources built for the people prescribing
Transform360 supports healthcare providers with plain-language clinical summaries, patient education tools, and up-to-date GLP-1 prescribing context — so your patients come to appointments better informed.
Who this is for
Built for the whole care team
Whether you're a primary care physician fielding questions about Ozempic, an endocrinologist managing complex metabolic cases, or an NP or PA supporting patients through their first months on a GLP-1 — these resources are designed to complement your clinical workflow.
Primary care physicians
Quick-reference summaries and patient-facing explainers to support GLP-1 conversations in a busy practice.
Endocrinologists
Detailed mechanism overviews and comparative medication profiles for complex metabolic and diabetes management.
Nurse practitioners & PAs
Practical prescribing context, side effect management guidance, and patient education handouts.
Pharmacists
Drug interaction summaries, dosing schedules, and storage guidance for the major GLP-1 receptor agonists.
What we offer
Clinical education, not clinical advice
All resources are for educational purposes only and do not constitute clinical guidelines or replace professional judgment.
Mechanism summaries
Clear, accurate explanations of how GLP-1 receptor agonists work — suitable for sharing with patients or refreshing your own understanding of the latest evidence.
Medication comparison profiles
Side-by-side overviews of semaglutide, tirzepatide, and liraglutide — covering approved indications, dosing schedules, efficacy data, and key safety considerations.
Patient-ready explainers
Plain-language articles your patients can read before or after appointments — covering how GLP-1s work, what to expect, and how to talk to their care team.
Side effect management guide
Practical strategies for managing the most common GLP-1 side effects — nausea, GI discomfort, injection site reactions — with evidence-based mitigation approaches.
FAQ for patients
A curated set of answers to the questions patients most commonly bring to appointments — covering safety, eligibility, cost, and realistic expectations.
Research updates
Summaries of significant new clinical trials and regulatory updates in the GLP-1 space, written for clinicians who want the signal without the noise.
Our editorial approach
How we handle clinical content
Evidence-based sourcing
All clinical content draws on peer-reviewed trials, FDA prescribing information, and guidance from major medical organizations including the ADA, AACE, and the Obesity Medicine Association.
Independent medical review
Key clinical content is reviewed by licensed physicians before publication. Reviewers have no financial relationship with any pharmaceutical manufacturer.
No pharmaceutical funding
Transform360 does not accept funding, advertising, or sponsored content from pharmaceutical companies, telehealth platforms, or compounding pharmacies. Our editorial independence is absolute.
Transparent versioning
When clinical content is updated to reflect new evidence or regulatory changes, we note what changed and when. The GLP-1 landscape evolves quickly — we keep pace honestly.
Stay current with the evidence
Sign up for the Transform360 newsletter and get plain-language summaries of new GLP-1 research, regulatory updates, and patient education tools — delivered to your inbox.